View Information Collection Request (ICR) Package
Skip to main content
An official website of the United States government
The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Search:
Agenda
Reg Review
ICR
This script is used to control the display of information in this page.
Display additional information by clicking on the following:
All
Brief and OIRA conclusion
Abstract/Justification
Legal Statutes
Rulemaking
FR Notices/Comments
IC List
Burden
Misc.
Common Form Info.
Certification
View Information Collection (IC) List
View Supporting Statement and Other Documents
Please note that the OMB number and expiration date may not have been determined when this Information Collection Request and associated Information Collection forms were submitted to OMB. The approved OMB number and expiration date may be found by clicking on the Notice of Action link below.
View ICR - OIRA Conclusion
OMB Control No:
0910-0732
ICR Reference No:
201603-0910-003
Status:
Historical Active
Previous ICR Reference No:
201510-0910-010
Agency/Subagency:
HHS/FDA
Agency Tracking No:
CTP
Title:
Reporting Harmful and Potentially Harmful Constituents in Tobacco Products and Tobacco Smoke Under the Federal Food, Drug, and Cosmetic Act
Type of Information Collection:
Extension without change of a currently approved collection
Common Form ICR:
No
Type of Review Request:
Regular
OIRA Conclusion Action:
Approved without change
Conclusion Date:
06/27/2016
Retrieve Notice of Action (NOA)
Date Received in OIRA:
03/21/2016
Terms of Clearance:
Approved consistent with the understanding that burden associated with HPHC reporting from manufacturers of newly deemed tobacco products are accounted for in OMB Control No. 0910-0768.
Inventory as of this Action
Requested
Previously Approved
Expiration Date
06/30/2019
36 Months From Approved
06/30/2016
Responses
281
0
1,896
Time Burden (Hours)
4,447
0
88,434
Cost Burden (Dollars)
0
0
0
Abstract:
This collection requires each tobacco product manufacturer or importer, or an agent, to report to FDA "all constituents, including smoke constituents, identified by [FDA] as harmful or potentially harmful to health in each tobacco product, and as applicable in the smoke of each tobacco product." These entities must also provide similar information at least 90 days prior to introducing the product into interstate commerce.
Authorizing Statute(s):
PL:
Pub.L. 111 - 111 31
Name of Law: The Family Smoking Prevention and Tobacco Control Act (the Tobacco Control Act)
Citations for New Statutory Requirements:
None
Associated Rulemaking Information
RIN:
Stage of Rulemaking:
Federal Register Citation:
Date:
Not associated with rulemaking
Other Documents for OIRA Review
Federal Register Notices & Comments
60-day Notice:
Federal Register Citation:
Citation Date:
80 FR 70232
11/13/2015
30-day Notice:
Federal Register Citation:
Citation Date:
81 FR 12501
03/09/2016
Did the Agency receive public comments on this ICR?
Yes
Number of Information Collection (IC) in this ICR:
4
IC Title
Form No.
Form Name
Additional HPHC reports
d, g, f, e, h, i, j
Annual Cigarette Report - Reporting of Harmful and Potentially Harmful Constituends
b, a, c
Annual Roll Your Own Tobacco Product Report - Reporting of Harmful and Potentially Harmful Constituents
a, b, c
Annual Smokeless Product Report - Reporting of Harmful and Potentially Harmful Constituents
a, b, c
Cigarette Reporting and Testing of Harmful and Potentially Harmful Constituents (in Accordance with Section 904(c)(1) of the FD&C Act)
a, b, c
Roll Your Own Tobacco Product Reporting and Testing of Harmful and Potentially Harmful Constituents (in Accordance with Section 904(c)(1) of the FD&C Act)
a, b, c
Smokeless Reporting and Testing of Harmful and Potentially Harmful Constituents (in Accordance with Section 904(c)(1) of the FD&C Act)
a, b, c
ICR Summary of Burden
Total Approved
Previously Approved
Change Due to New Statute
Change Due to Agency Discretion
Change Due to Adjustment in Estimate
Change Due to Potential Violation of the PRA
Annual Number of Responses
281
1,896
0
-1,615
0
0
Annual Time Burden (Hours)
4,447
88,434
0
-83,987
0
0
Annual Cost Burden (Dollars)
0
0
0
0
0
0
Burden increases because of Program Change due to Agency Discretion:
Yes
Burden Increase Due to:
Miscellaneous Actions
Burden decreases because of Program Change due to Agency Discretion:
Yes
Burden Reduction Due to:
Miscellaneous Actions
Short Statement:
This collection of information is an extension with changes and reflects an adjustment in its inventory since last approved by OMB. FDA estimates there will be a decrease in the burden by 83,987 hours and 1,010 responses (from 88,434 hours and 1,896 responses in the currently approved ICR to 4,447 hours and 886 responses in the proposed ICR).
Annual Cost to Federal Government:
$376,000
Does this IC contain surveys, censuses, or employ statistical methods?
No
Is the Supporting Statement intended to be a Privacy Impact Assessment required by the E-Government Act of 2002?
No
Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]?
No
Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]?
No
Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)?
No
Is this ICR related to the Pandemic Response?
Uncollected
Agency Contact:
Amber Sanford 301 796-8867 amber.sanford@fda.hhs.gov
Common Form ICR:
No
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(a) It is necessary for the proper performance of agency functions;
(b) It avoids unnecessary duplication;
(c) It reduces burden on small entities;
(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;
(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;
(f) It indicates the retention periods for recordkeeping requirements;
(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.
(i) It uses effective and efficient statistical survey methodology (if applicable); and
(j) It makes appropriate use of information technology.
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
Certification Date:
03/21/2016
An official website of the United States government
The .gov means it's official.
The site is secure.
